Plain-English translation of NCT07399418 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The TRIAD study is looking for better ways to catch Alzheimer's disease in its earliest stages—before symptoms become obvious. Researchers will use blood tests for brain inflammation markers, brain imaging, memory assessments, and conversations about your life and relationships to build a complete picture of your brain health. This approach aims to find problems early, when there may be more options to help.
Current methods to diagnose Alzheimer's early are expensive, invasive, or difficult to access. This study is exploring whether simpler blood tests combined with information about your psychology, social life, and caregiver's well-being can catch the disease sooner and more accurately.
You likely qualify if…
You likely don't qualify if…
You and your caregiver will likely visit the research clinic for assessments that include blood draws for biomarkers, brain imaging scans, memory and thinking tests, and interviews about your mood, relationships, and how caregiving is affecting you both. The study will help researchers understand how your brain changes, your psychological well-being, and your caregiver's experience all work together in the early stages of cognitive decline.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Italy